Cadmium has been studied in 234 papers since 2016: 192 observational studies in people, 13 in animals, 26 reviews; 80 in the past year. It has not reached trials in people. The newest story, Nov 9, 2026: “Urinary cadmium linked to higher blood inflammation marker”.
Independent labs report shortened fly lifespan and human links with worse cognition and age-related macular degeneration, although a fly study shows no clear lifespan effect at 10 μM. Human cohorts also link cadmium with higher biological age. The National Natural Science Foundation of China supports work, and some authors have AstraZeneca or Hitachi affiliations.
194 findings in 136 papers from 2016 to 2026, 27 of them since April 2026
Independent labs found the same change in cells, worms or flies, mice and people. 82 independent labs in 17 countries.
“this association was partly mediated by cadmium exposure”
Cells, worms or flies, mice and humans: replicated by independent labs.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
82 independent labs in 17 countries
9 findings against
Funders: National Natural Science Foundation of China and others
2 of 188 findings with company ties
Humans191
Animals11
Model organisms2
In silico1
What did studies of cadmium find?
54
Studies of cadmium measured 54 outcomes; the most studied are cognitive function (15 studies), cellular senescence (6) and lifespan (2).
Cognitive function
↓downin humans11↓downin mice3↓downin rats1
15 studies
Cadmium is linked with worse cognitive function in humans (HUCd (>5 μg/g creatinine) vs LUCd (≤5 μg/g creatinine)).
“Participants in the HUCd group showed significantly lower scores across multiple MCCB domains, including verbal learning, working memory, and overall cognition, compared with those in the LUCd group.”
Cadmium is linked with worse cognitive function in humans (β: -2.02; 95% CI: -3.19, -0.85).
“cadmium (β: -2.02; 95% CI: -3.19, -0.85) were inversely associated and serum 25(OH)D (β: 2.23; 95% CI: 0.88, 3.59) was positively associated with the Digit Symbol Substitution Test (DSST) score”
Cadmium is linked with worse cognitive function in humans (adjusted single-metal models) (β = - 0.37, 95% CI: - 0.73 to - 0.01).
“In the adjusted single-metal models, both Cd (β = - 0.37, 95% CI: - 0.73 to - 0.01) and Pb (β = - 0.44, 95% CI: - 0.86 to - 0.02) were associated with MMSE scores”
Cadmium is linked with worse renal tubular function in humans (baseline urinary Cd level ≥7 μg/g cr).
“however, farmers ≥70 years with a baseline urinary Cd level ≥7 μg/g cr. had elevated urinary α1-microglobulin and ß2-microglobulin levels, indicating the deterioration of renal tubular function.”
Cadmium is associated with mortality in humans (Nonalcoholic fatty liver disease) (HR 3.62, 95% CI 1.08–12.12; mortality rates 4.2 to 18.0 per 1000 person-years across quartiles; p for trend=0.008).
“Participants in the highest cadmium quartile had a hazard ratio (HR) of 3.62 (95 % CI: 1.08-12.12) compared to the lowest quartile”
HumansNonalcoholic fatty liver diseaseHighest versus lowest cadmium quartileMedian follow-up of 23.6 monthsn = 1,787
Cadmium is linked with a higher risk of mortality in humans (frail patients) (HR 1.96, 95% CI 1.53-2.52).
“higher the exposure levels to cadmium and lead, the higher the risk of death in frail patients, with associated hazard ratios (HR) of 95% CI: 1.96 (1.53, 2.52) and 1.30 (1.13, 1.49)”
Archives of public health = Archives belges de sante publique·
Cadmium is linked with a higher risk of mortality in humans.
“Higher cadmium concentrations in blood and urine were significantly related to an increase in all-cause mortality for postmenopausal females after adjustment for multivariate covariates.”
Cadmium is associated with chronic kidney disease in humans (single-metal model) (OR 1.48, 95% CI 1.30–1.69).
“cadmium (OR = 1.48, 95% CI 1.30–1.69; P < 0.001) and lead (OR = 1.36, 95% CI 1.18–1.57; P < 0.001) showed the strongest positive associations with CKD.”
Cadmium is linked with a higher risk of chronic kidney disease in humans (OR 1.52 (95% CI: 1.31-1.76) for Q4 vs Q1).
“With regard to blood cadmium concentrations, the ORs for CKD in Q2, Q3, and Q4 were 1.06 (95% CI: 0.92-1.22), 1.21 (95% CI: 1.05-1.39), and 1.52 (95% CI: 1.31-1.76), respectively.”
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)·
Cadmium is linked with a higher risk of chronic kidney disease in humans (comparing fourth to first quartile of blood Cd) (OR 1.77).
“The ORs for the risk of CKD comparing the fourth to the first quartile of blood Cd, blood Hg, urine Cd, and urine Hg were 1.77, 1.57, 2.03, and 1.50, respectively.”
Humanscomparing fourth to first quartile of blood Cd
Cadmium is associated with chronic kidney disease in humans.
“Large-scale observational studies consistently report associations between cadmium, lead, and arsenic exposure and higher CKD risk and faster eGFR decline.”
Cadmium is linked with a higher risk of osteoporosis in humans (fully adjusted model) (OR 8.563, 95% CI 1.888 to 38.845).
“Cd was positively associated with femoral neck osteoporosis in men aged ≥50 years [odds ratio (OR)=8.563, 95% confidence interval (CI) 1.888 to 38.845, P<0.05]”
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·
Cadmium is linked with a higher risk of osteoporosis in humans (total population; logistic regression, quartile 4 versus reference) (OR 1.989 (95% CI 1.379-2.870) for Q4).
“cadmium (ORQ4 = 1.989, 95% CI = 1.379-2.870) were positively correlated”
Humanstotal population; logistic regression, quartile 4 versus reference
Cadmium is associated with GrimAge in humans (1.617 units per IQR increase).
“Each interquartile range unit increase in urinary cadmium was associated with increases of 1.617, 1.874, and 0.023 units in GrimAge-Resid, GrimAge2-Resid, and DunedinPoAm, respectively.”
Cadmium is linked with a higher risk of cardiovascular disease in humans (per IQR increase via longitudinal trajectory of CAC) (44 (20, 72) per 100,000 person-years).
“The number of CVD cases (95% CI) per 100,000 person-years attributable to an interquartile range (IQR) increase in metal levels through the longitudinal trajectory of CAC was 44 (20, 72) for cadmium”
Humansper IQR increase via longitudinal trajectory of CAC
Cadmium is linked with a higher risk of depression in humans (OR 1.22, 95% CI 1.04–1.43).
“We found a significant positive association between blood cadmium and depression with an odds ratio (OR) and 95% confidence interval (CI): 1.22 (1.04,1.43).”
Environmental science and pollution research international·
Cadmium is associated with depression in humans (OR 1.27, 95% CI 1.06-1.52).
“Interquartile-range increase (0.645 μg/L) in blood cadmium levels was associated with depression defined as SGDS-K score ≥8 (odds ratio = 1.27, 95% confidence interval: 1.06, 1.52)”
Cadmium is linked with a higher risk of sarcopenia in humans after adjustment for confounding factors; quartile categories.
“odds ratio for sarcopenia were increased with concentration category of lead (P=0.005 and P<0.001), mercury (P=0.001 and P<0.001) and cadmium (P=0.010 and P<0.001)”
Humansafter adjustment for confounding factors; quartile categoriesmale and femalesn = 704
Cadmium is associated with soluble urokinase plasminogen activator receptor in humans (Adjusted for smoking status and pack-years) (7.81% higher suPAR per IQR increase in urinary cadmium (95% CI 5.96–9.69)).
“Each IQR increase in urinary cadmium was associated with 7.81% higher suPAR (95% CI 5.96, 9.69).”
HumansAdjusted for smoking status and pack-yearsserumPer IQR increase in urinary cadmium48.4% womensn = 5,178
Cadmium is associated with soluble urokinase plasminogen activator receptor in humans (Free of clinical cardiovascular disease at baseline) (7.99% higher suPAR per IQR; 95% CI, 6.14–9.87).
“cadmium showed the strongest association (7.99% higher suPAR per IQR; 95% CI, 6.14–9.87)”
HumansFree of clinical cardiovascular disease at baselineSerumPer interquartile-range increase in urinary cadmiumn = 5,148
National Institute of Arthritis and Musculoskeletal and Skin Diseases$3.8MNational Institute of Environmental Health Sciences$1.4MNational Cancer Institute$380K
Independent labs report shorter fly lifespan with cadmium and associations with age-related macular degeneration in humans; human studies also link exposure to accelerated biological aging. A fly study reports no lifespan change at 10 μM but shortening and slower cardiac aging at 100 μM. Cell experiments also report senescence in annulus fibrosus cells.
Human studies associate cadmium with gestational diabetes, mild cognitive impairment and albuminuria. A human preprint links it to chronic kidney disease of unknown etiology; another reports cadmium nephropathy after prolonged high exposure and impaired renal tubular function at high urinary cadmium levels in women.
In 6,553 adults, combined exposure to six chemicals was linked to biological age acceleration, with an odds ratio of 1.58.In 6,553 adults, combined exposure to six chemicals was linked to biological age acceleration, with an odds ratio of 1.58.
A doubling of exposure to the chemical 2-hydroxyfluorene was linked to a 0.491-year increase in a DNA-based measure of accelerated aging.A doubling of exposure to the chemical 2-hydroxyfluorene was linked to a 0.491-year increase in a DNA-based measure of accelerated aging.
Each increase spanning the middle half of urinary cadmium measurements was linked to 7.81% higher levels of a marker of chronic inflammation.Each increase spanning the middle half of urinary cadmium measurements was linked to 7.81% higher levels of a marker of chronic inflammation.
An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.